Sleep Length and Euploid Embryo Transfer Prospective Study
Launched by NORTHWESTERN UNIVERSITY · Nov 15, 2023
Trial Information
Current as of November 02, 2025
Recruiting
Keywords
ClinConnect Summary
The SLEEP Study is researching how sleep affects women's fertility, specifically during the process of in vitro fertilization (IVF). Researchers want to understand if getting better sleep can improve the chances of a successful embryo transfer. To do this, they will have participants wear a small device on their finger that tracks their sleep patterns for several weeks before and after the embryo transfer.
Women who are between the ages of 18 and 44 and are preparing for their first, second, or third frozen embryo transfer may be eligible to join this study. However, those with certain conditions, like polycystic ovary syndrome or a very high body mass index, and those who have had multiple failed transfers or significant uterine surgery, will not be included. Participants will track their sleep and may learn more about how their sleep habits impact their fertility journey. This study could help develop new ways to support women in achieving their pregnancy goals.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Undergoing a single euploid frozen embryo transfer
- • Patient's 1st, 2nd, or 3rd embryo transfer (prior fresh or frozen transfers included)
- Exclusion Criteria:
- • Primary infertility diagnosis of polycystic ovary syndrome
- • BMI \> 40
- • Diagnosis of primary ovarian insufficiency (FSH \> 40)
- • Night work
- • High risk of poor outcomes of fertility treatment \[\> 2 prior miscarriages (women with recurrent pregnancy loss), significant uterine factor infertility \[\>/= 2 myomectomies (open abdominal or laparoscopic) or any non-hystoeroscopic myomectomy entering the endometrial cavity\]
- • Undergoing medical fertility preservation for a significant medical co-morbidity
- • Current cancer diagnosis
- • \> 3 prior failed embryo transfers in attempt for current live birth
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Jessica Walter, MD, MSCE
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported